AORT insider transaction filings
ARTIVION, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-20. Screen AORT transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4 | Mackin James P — President & CEO | Sale (S): 70,000 @ $28.95 | EDGAR |
| 2026-08-17 | 4 | Berry Lance A — EVP, COO, CFO & Treasurer | Sale (S): 715 @ $28.55 | EDGAR |
| 2026-08-17 | 4 | GREEN ANDREW M — SVP, Regulatory and Quality | Sale (S): 616 @ $28.55 | EDGAR |
| 2026-08-12 | 4 | Holloway Jean F — SVP, General Counsel | Sale (S): 977 @ $28.49 | EDGAR |
| 2026-06-15 | 4 | GREEN ANDREW M — SVP, Regulatory and Quality | Option exercise (M): 14,001 @ $18.44 · Sale (S): 14,001 @ $20.71 · Option exercise (M): 30,000 @ $11.03 · Sale (S): 30,000 @ $20.69 · Option exercise (M): 14,001 (derivative) @ $0 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | SEMEDO ANTHONY B. — Director | Other (J): 6,325 @ $0 · Other (J): 6,325 @ $0 | EDGAR |
| 2026-05-20 | 4 | Hoff Elizabeth A — Director | Grant/award (A): 7,576 @ $0 | EDGAR |
| 2026-05-20 | 4 | SEMEDO ANTHONY B. — Director | Grant/award (A): 7,576 @ $0 | EDGAR |
| 2026-05-20 | 4/A | Borgstrom Marna P — Director | Grant/award (A): 7,576 @ $0 | EDGAR |
| 2026-05-20 | 4 | Salveson Jon W — Director | Grant/award (A): 7,576 @ $0 | EDGAR |
| 2026-05-20 | 4 | Burbank Jeffrey H — Director | Grant/award (A): 7,576 @ $0 | EDGAR |
| 2026-05-20 | 4 | BEVEVINO DANIEL J — Director | Grant/award (A): 7,576 @ $0 | EDGAR |
| 2026-05-20 | 4 | Bullock James — Director | Grant/award (A): 7,576 @ $0 | EDGAR |
| 2026-05-20 | 4 | ACKERMAN THOMAS F — Director | Grant/award (A): 7,576 @ $0 | EDGAR |
| 2026-05-19 | 4 | Borgstrom Marna P — Director | Grant/award (A): 7,850 @ $0 | EDGAR |
| 2026-03-04 | 4 | Stanton Marshall S. — SVP, Clinical & MD Affair | Grant/award (A): 21,838 @ $0 · Sale (S): 2,149 @ $37.78 | EDGAR |
| 2026-03-04 | 4 | Davis John E — Chief Commercial Officer | Grant/award (A): 28,845 @ $0 · Sale (S): 4,573 @ $37.78 | EDGAR |
| 2026-03-04 | 4 | Holloway Jean F — SVP, General Counsel | Grant/award (A): 27,795 @ $0 · Sale (S): 3,843 @ $37.78 · Sale (S): 8,962 @ $38 | EDGAR |
| 2026-03-04 | 4 | Berry Lance A — EVP, COO, CFO & Treasurer | Grant/award (A): 40,874 @ $0 · Sale (S): 6,316 @ $37.78 | EDGAR |
| 2026-03-04 | 4 | Mackin James P — President & CEO | Grant/award (A): 116,948 @ $0 · Sale (S): 17,887 @ $37.78 | EDGAR |
| 2026-03-04 | 4 | Horton Amy — VP, Chief Accounting Officer | Grant/award (A): 7,475 @ $0 · Sale (S): 901 @ $37.78 | EDGAR |
| 2026-03-03 | 4 | Stanton Marshall S. — SVP, Clinical & MD Affair | Sale (S): 1,513 @ $38.02 | EDGAR |
| 2026-03-03 | 4 | Davis John E — Chief Commercial Officer | Sale (S): 2,784 @ $38.02 | EDGAR |
| 2026-03-03 | 4 | Holloway Jean F — SVP, General Counsel | Sale (S): 2,183 @ $38.02 | EDGAR |
| 2026-03-03 | 4 | Berry Lance A — EVP, COO, CFO & Treasurer | Sale (S): 5,178 @ $38.02 | EDGAR |
| 2026-03-03 | 4 | Mackin James P — President & CEO | Sale (S): 14,911 @ $38.02 | EDGAR |
| 2026-03-03 | 4 | Horton Amy — VP, Chief Accounting Officer | Sale (S): 641 @ $38.02 | EDGAR |
| 2026-02-25 | 4 | Stanton Marshall S. — SVP, Clinical & MD Affair | Sale (S): 2,423 @ $37.59 · Sale (S): 1,259 @ $35.69 | EDGAR |
| 2026-02-25 | 4 | Davis John E — Chief Commercial Officer | Sale (S): 3,773 @ $37.59 · Sale (S): 2,075 @ $35.69 · Grant/award (A): 20,438 @ $0 | EDGAR |
| 2026-02-25 | 4 | Holloway Jean F — SVP, General Counsel | Sale (S): 3,079 @ $37.59 · Sale (S): 1,668 @ $35.69 · Grant/award (A): 20,085 @ $0 | EDGAR |
| 2026-02-25 | 4 | Berry Lance A — EVP, COO, CFO & Treasurer | Sale (S): 4,981 @ $37.59 · Sale (S): 4,485 @ $35.69 · Grant/award (A): 37,482 @ $0 | EDGAR |
| 2026-02-25 | 4 | Mackin James P — President & CEO | Sale (S): 20,962 @ $37.59 · Sale (S): 13,936 @ $35.69 · Grant/award (A): 97,030 @ $0 | EDGAR |
| 2026-02-25 | 4 | Horton Amy — VP, Chief Accounting Officer | Sale (S): 1,731 @ $37.59 · Sale (S): 830 @ $35.69 · Grant/award (A): 5,658 @ $0 | EDGAR |
| 2025-12-17 | 4 | Davis John E — Chief Commercial Officer | Sale (S): 5,000 @ $45.11 | EDGAR |
| 2025-12-09 | 4 | Horton Amy — VP, Chief Accounting Officer | Sale (S): 4,572 @ $44.42 | EDGAR |
| 2025-12-04 | 4 | Holloway Jean F — SVP, General Counsel | Sale (S): 2,048 @ $45.30 · Sale (S): 5,267 @ $45.30 | EDGAR |
| 2025-12-04 | 4 | Mackin James P — President & CEO | Option exercise (M): 30,921 @ $29.62 · Sale (S): 30,921 @ $45.46 · Option exercise (M): 30,921 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Mackin James P — President & CEO | Option exercise (M): 30,921 @ $29.62 · Sale (S): 30,921 @ $45.56 · Option exercise (M): 30,921 (derivative) @ $0 | EDGAR |
| 2025-12-02 | 4 | Horton Amy — VP, Chief Accounting Officer | Gift (G): 750 @ $0 | EDGAR |
| 2025-11-24 | 4 | Stanton Marshall S. — SVP, Clinical & MD Affair | Option exercise (M): 20,301 @ $18.44 · Sale (S): 14,586 @ $44.92 · Sale (S): 5,715 @ $45.35 · Option exercise (M): 27,075 @ $11.03 · Sale (S): 18,705 @ $44.91 · Sale (S): 8,370 @ $45.34 · +2 more | EDGAR |
| 2025-11-24 | 4 | Stanton Marshall S. — SVP, Clinical & MD Affair | Sale (S): 11,888 @ $44.14 · Option exercise (M): 2,033 @ $18.44 · Sale (S): 2,033 @ $44.31 · Option exercise (M): 1,355 @ $11.03 · Sale (S): 1,355 @ $44.28 · Option exercise (M): 2,033 (derivative) @ $0 · +1 more | EDGAR |
| 2025-11-19 | 4 | Hoff Elizabeth A — Director | Sale (S): 4,200 @ $45.10 | EDGAR |
| 2025-11-18 | 4 | Davis John E — Chief Commercial Officer | Option exercise (M): 6,393 @ $29.62 · Sale (S): 6,393 @ $44.67 · Option exercise (M): 6,394 @ $29.62 · Sale (S): 6,394 @ $45.17 · Option exercise (M): 6,393 (derivative) @ $0 · Option exercise (M): 6,394 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Holloway Jean F — SVP, General Counsel | Option exercise (M): 6,393 @ $29.62 · Sale (S): 6,393 @ $45 · Option exercise (M): 6,394 @ $29.62 · Sale (S): 6,394 @ $45.17 · Option exercise (M): 6,393 (derivative) @ $0 · Option exercise (M): 6,394 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Horton Amy — VP, Chief Accounting Officer | Sale (S): 6,000 @ $45.73 | EDGAR |
| 2025-11-14 | 4 | Stanton Marshall S. — SVP, Clinical & MD Affair | Sale (S): 4,993 @ $45.86 | EDGAR |
| 2025-11-14 | 4 | Davis John E — Chief Commercial Officer | Sale (S): 6,563 @ $45.86 | EDGAR |
| 2025-11-14 | 4 | Holloway Jean F — SVP, General Counsel | Sale (S): 5,761 @ $45.86 | EDGAR |
| 2025-11-14 | 4 | Mackin James P — President & CEO | Sale (S): 34,210 @ $45.86 | EDGAR |
| 2025-11-14 | 4 | Horton Amy — VP, Chief Accounting Officer | Sale (S): 3,482 @ $45.86 | EDGAR |
Recent 8-K events — ARTIVION, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-18 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AORT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →